Combined blockade of CXCR4 and PD-1 enhances intratumoral dendritic cell activation and immune responses against HCC
S. Morita, K. Shigeta, P. Lei, T. Kobayashi, H. Kikuchi, A. Matsui, P. Huang, M. Pittet, D. Duda
This study shows that blocking CXCR4 and PD-1 together improves dendritic cell activation and immune responses against HCC in mouse models.
bioRxiv · Nov 6, 2023 · PreprintCancer Biology